To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia
Clinical trial NCT05890053 · COMPLETED
Trial details
- NCT number
- NCT05890053
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-17
- Primary completion
- 2023-07-30
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.